Package 68001-540-36

Brand: bortezomib

Generic: bortezomib
NDC Package

Package Facts

Identity

Package NDC 68001-540-36
Digits Only 6800154036
Product NDC 68001-540
Product ID 68001-540_df1f04a5-b5bc-73e6-e053-2a95a90aa6d4
Description

1 VIAL in 1 CARTON (68001-540-36) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Marketing

Marketing Status
Marketed Since 2022-05-16
Brand bortezomib
Generic bortezomib
Sample Package No

Linked Drug Pages (1)

Bortezomib ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "df1f04a5-b5bc-73e6-e053-2a95a90aa6d4", "openfda": {"nui": ["N0000175604", "N0000175075"], "unii": ["69G8BD63PP"], "rxcui": ["402243"], "spl_set_id": ["12500f21-8e2f-4bcd-861e-4dfca843da2e"], "pharm_class_epc": ["Proteasome Inhibitor [EPC]"], "pharm_class_moa": ["Proteasome Inhibitors [MoA]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (68001-540-36)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL", "package_ndc": "68001-540-36", "marketing_start_date": "20220516"}], "brand_name": "Bortezomib", "product_id": "68001-540_df1f04a5-b5bc-73e6-e053-2a95a90aa6d4", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Proteasome Inhibitor [EPC]", "Proteasome Inhibitors [MoA]"], "product_ndc": "68001-540", "generic_name": "Bortezomib", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bortezomib", "active_ingredients": [{"name": "BORTEZOMIB", "strength": "3.5 mg/1"}], "application_number": "ANDA210824", "marketing_category": "ANDA", "marketing_start_date": "20220516", "listing_expiration_date": "20261231"}